Dr. Burkhard Wandelt works for the Merck Group since more than 12 years and is the Director of Engineering & Technology as well as Head of  the Global Maintenance Management Program.

Our Healthcare business is dedicated to providing innovative therapies with the goal of helping to create, improve and transform patients’ lives. The sector consists of these areas: Biopharma and Allergopharma. This structure enables us to drive pipeline projects that aim to deliver groundbreaking and speciality new medicines to patients. The Biopharma portfolio focuses on the specialized therapeutic areas of oncology, neurology & immunology, fertility and general medicine & endocrinology. The Allergopharma portfolio comprises diagnostics and products used in allergen immunotherapy (AIT). With our own research department, and in cooperation with research institutes and other partners, we are committed to developing a better understanding of the immunological mechanism that underlies the development of allergies. About Merck Healthcare As the largest of Merck’s three business sectors (Healthcare, Life Science and Performance Materials), Merck Healthcare is dedicated to driving innovation in science and technology for real improvement of patients’ lives. Its 20.000 employees around the world work in Europe, North America, Asia, Africa and Latin America.